Evaluation of a convenient enzyme immunoassay to assess the quality of genital specimens submitted for the detection of human papillomavirus DNA by consensus PCR

Journal of Clinical Virology

Volumn 29, Issue 2, 2004, Pages 127-133

  Aho, Joséphine ^a   Kornegay, Janet R ^b   Healey, Sylvia ^c   Roger, Michel ^a,d   Dion, France ^a   Gaudreault, Diane ^a   Shepard, Amanda P ^b   Franco, Eduardo L ^e   Coutlée, Francois ^a,d,e  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b ROCHE MOLECULAR SYSTEMS   (United States)

^c Government of Nunavut   (Canada)

^d NOTRE DAME HOSPITAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Cervical sample; HPV; Inhibitors; Quality control; Sample quality; Globin PCR

Indexed keywords

BETA GLOBIN; DIGOXIGENIN; VIRUS DNA;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTERMETHOD COMPARISON; MICROTITER PLATE ASSAY; OPTICAL DENSITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX; VALIDATION PROCESS; VIRUS DETECTION; WART VIRUS;

EID: 1642512658     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(03)00114-8     Document Type: Article

References (31)

1. Bauer H.M., Greer C.E., Manos M.M. Determination of genital human papillomavirus infection by consensus polymerase chain reaction amplification. Herrington C.S., McGee J.O.D. Diagnostic molecular pathology, a practical approach. 1992;131-152 IRL Press, Oxford.
2. Bosch F.X., Lorincz A., Munoz N., Meijer C.J.L.M., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:2002;244-265.
3. Center for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections. Morbid Mortal Weekly Rep 1993;42:1-39.
4. Coutlée F., Mayrand M.H., Provencher D., Franco E. The future of HPV testing in clinical laboratories and applied virology research. Clin. Diagn. Virol. 8:1997;123-141.
5. Coutlée F., Trottier A.M., Ghattas G., Leduc R., Toma E., Sanche G., et al. Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus. Sex. Transm. Dis. 24:1997;23-31.
6. Coutlée F., de Ladurantaye M., Tremblay C., Vincelette J., Labrecque L., Roger M. An important proportion of genital samples submitted for Chlamydia trachomatis detection by PCR contain small amounts of cellular DNA as measured by beta-globin gene amplification. J. Clin. Microbiol. 38:2000;2512-2515.
7. Coutlée F., Gravitt P., Kornegay J., Hankins C., Richardson H., Lapointe J.R., et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J. Clin. Microbiol. 40:2002;902-907.
8. Fleiss J.L. Statistical methods for rates and proportions. 1981;Wiley, New York.
9. Gravitt P., Peyton C.L., Apple R.J., Wheeler C. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36:1998;3020-3027.
10. Gravitt P., Peyton C.L., Alessi T.Q., Wheeler C., Coutlée F., Hildesheim A., et al. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:2000;357-361.
11. Healey S.M., Aronson K.J., Mao Y., Schlecht N.F., Mery L.S., Ferenczy A., et al. Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada. Sex. Transm. Dis. 28:2001;694-700.
12. Jacobs M.V., Snidjers P.J.F., van den Brule A.J.C., Helmerhorst T.J.M., Meijer C., Walboomers J. A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 35:1997;791-795.
13. Kellogg J.A. Impact of variation in endocervical specimen collection and testing techniques on frequency of false-positive and false-negative Chlamydia detection results. Am. J. Clin. Pathol. 104:1995;554-559.
14. Kellogg J.A., Seiple J.W., Klinedinst J.L., Stroll E.S., Cavanaugh S.H. Improved PCR detection of Chlamydia trachomatis by using an altered method of specimen transport and high-quality endocervical specimens. J. Clin. Microbiol. 33:1995;2765-2767.
15. Kellogg J.A., Seiple J.W., Murray C.L., Levisky J.S. Effect of endocervical specimen quality on detection of Chlamydia trachomatis and on the incidence of false-positive results with the Chlamydiazyme method. J. Clin. Microbiol. 28:1990;1108-1113.
16. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M, Quint W. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-17.
17. Kornegay J.R., Shepard A.P., Hankins C., Franco E., Lapointe N., Richardson H. Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunoassay format. J. Clin. Microbiol. 39:2001;3530-3536.
18. Mahony J.B., Chong S., Jang D., Luinstra K.E., Faught M., Dalby D., et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J. Clin. Microbiol. 36:1998;3122-3126.
19. Peyton C.L., Schiffman M., Lorincz A.T., Hunt W.C., Mielzynska I., Bratti C., et al. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J. Clin. Microbiol. 36:1998;3248-3254.
20. Phillips R.S., Hanff P.A., Kaufman R.S., Aronson M.D. Use of a direct fluorescent antibody test for detecting Chlamydia trachomatis cervical infection in women seeking routine gynecologic care. J. Infect. Dis. 156:1987;575-581.
21. Poljak M., Seme K. Rapid detection and typing of human papillomaviruses by consensus polymerase chain reaction and enzyme-linked immunosorbent assay. J. Virol. Methods. 56:1996;231-238.
22. Quint W.G.V., Scholte G., van Doorn L.J., Kleter B., Smits P.H.M., Lindeman J. Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF10 PCR and HPV genotyping. J. Pathol. 194:2002;51-58.
23. Sherman M.E., Schiffman M.H., Lorincz A.T., Herrero R., Hutchinson M.L., Bratti C., et al. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer. 81:1997;89-97.
24. Swan D.C., Tucker R.A., Tortolero-Luna G., Mitchell M.F., Wideroff L., Unger E.R., et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37:1999;1030-1034.
25. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesoins: baseline data from a randomized trial. J. Natl. Cancer Inst. 92:2000;397-402.
26. Toye B., Woods W., Bobrowska M., Ramotar K. Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing. J. Clin. Microbiol. 36:1998;2358.
27. van den Brule A.J.C., Pol R., Fransen-Daalmeijer N., Schouls L.M., Meijer C.J.L.M., Snidjers P.J.F. GP5+/GP6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:2002;779-787.
28. van Duin M., Snidjers P.J.F., Schrijnemakers H.F.J., Voorhorst F.J., Rozendaal L., Nobbenhuis M.A.E., et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int. J. Cancer. 98:2002;590-595.
29. Welsh L.E., Quinn T.C., Gaydos C. Influence of endocervical specimen adequacy on PCR and direct fluorescent-antibody staining for detection of Chlamydia trachomatis infections. J. Clin. Microbiol. 35:1997;3078-3081.
30. Zehbe I., Wilander E. Nonisotopic ELISA-based detection of human papillomavirus-amplified DNA. Mod. Pathol. 10:1997;188-191.
31. Zerbini M., Venturoli S., Cricca M., Gallinella G., De Simone P., Costa S., et al. Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA. J. Clin. Pathol. 54:2001;377-380.